203 related articles for article (PubMed ID: 8774572)
1. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.
Barr H; Shepherd NA; Dix A; Roberts DJ; Tan WC; Krasner N
Lancet; 1996 Aug; 348(9027):584-5. PubMed ID: 8774572
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
[TBL] [Abstract][Full Text] [Related]
3. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.
Ackroyd R; Kelty CJ; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Endoscopy; 2003 Jun; 35(6):496-501. PubMed ID: 12783347
[TBL] [Abstract][Full Text] [Related]
4. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization.
Messmann H; Knüchel R; Bäumler W; Holstege A; Schölmerich J
Gastrointest Endosc; 1999 Jan; 49(1):97-101. PubMed ID: 9869731
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.
Barr H
Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):421-37. PubMed ID: 10899256
[TBL] [Abstract][Full Text] [Related]
7. Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
Brand S; Wang TD; Schomacker KT; Poneros JM; Lauwers GY; Compton CC; Pedrosa MC; Nishioka NS
Gastrointest Endosc; 2002 Oct; 56(4):479-87. PubMed ID: 12297761
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia.
Tan WC; Fulljames C; Stone N; Dix AJ; Shepherd N; Roberts DJ; Brown SB; Krasner N; Barr H
J Photochem Photobiol B; 1999; 53(1-3):75-80. PubMed ID: 10672532
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study.
Javaid B; Watt P; Krasner N
Lasers Med Sci; 2002; 17(1):51-6. PubMed ID: 11845368
[TBL] [Abstract][Full Text] [Related]
11. [Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
Ortner M; Lochs H
Z Gastroenterol; 1998 Jan; 36(1):111-3. PubMed ID: 9531692
[No Abstract] [Full Text] [Related]
12. Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
Dunn J; Lovat L
Expert Opin Pharmacother; 2008 Apr; 9(5):851-8. PubMed ID: 18345960
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.
Gossner L; Stolte M; Sroka R; Rick K; May A; Hahn EG; Ell C
Gastroenterology; 1998 Mar; 114(3):448-55. PubMed ID: 9496934
[TBL] [Abstract][Full Text] [Related]
14. Treatment for Barrett's oesophagus.
Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation.
Endlicher E; Knuechel R; Hauser T; Szeimies RM; Schölmerich J; Messmann H
Gut; 2001 Mar; 48(3):314-9. PubMed ID: 11171819
[TBL] [Abstract][Full Text] [Related]
16. Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy.
Mackenzie GD; Dunn JM; Selvasekar CR; Mosse CA; Thorpe SM; Novelli MR; Bown SG; Lovat LB
Lasers Med Sci; 2009 Sep; 24(5):729-34. PubMed ID: 19057983
[TBL] [Abstract][Full Text] [Related]
17. Barrett's oesophagus: new diagnostic and therapeutic techniques.
Haringsma J
Scand J Gastroenterol Suppl; 2002; (236):9-14. PubMed ID: 12408497
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.
Ackroyd R; Brown NJ; Davis MF; Stephenson TJ; Marcus SL; Stoddard CJ; Johnson AG; Reed MW
Gut; 2000 Nov; 47(5):612-7. PubMed ID: 11034574
[TBL] [Abstract][Full Text] [Related]
19. Time gated fluorescence spectroscopy in Barrett's oesophagus.
Ortner MA; Ebert B; Hein E; Zumbusch K; Nolte D; Sukowski U; Weber-Eibel J; Fleige B; Dietel M; Stolte M; Oberhuber G; Porschen R; Klump B; Hörtnagl H; Lochs H; Rinneberg H
Gut; 2003 Jan; 52(1):28-33. PubMed ID: 12477755
[TBL] [Abstract][Full Text] [Related]
20. Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus.
Ackroyd R; Brown NJ; Davis MF; Stephenson TJ; Stoddard CJ; Reed MW
Dis Esophagus; 2000; 13(1):18-22. PubMed ID: 11005326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
